Literature DB >> 34386208

Enhancing Electronic Health Systems to End Transmission of Chronic Hepatitis B During COVID-19: A Collaborative Approach.

Eric Chak1, Fresnia Vu2, Julie Dang3, Ulissa Smith4, Susan Stewart5, Karman Tam6, Amy Beste-Fong6, Breanna Phelps7, Ian Johnson2, Miguel Suarez2, Mary Pat Pauly8, Moon S Chen9.   

Abstract

Entities:  

Year:  2021        PMID： 34386208      PMCID： PMC8340353          DOI： 10.1002/cld.1144

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  9 in total

1.  Healthcare Disparities Identified Between Hmong and Other Asian Origin Groups Living with Chronic Hepatitis B Infection in Sacramento County 2014-2017.

Authors:  Timothy Wang; Yu Liu; Duke Letran; Julie Ha Thi Dang; Aaron M Harris; Chin-Shang Li; Moon S Chen; Christopher L Bowlus; Eric Chak
Journal:  J Community Health       Date:  2020-04

2.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Linda Harrison; Luc Decker; Woottichai Khamduang; Camlin Tierney; Nicolas Salvadori; Tim R Cressey; Wasna Sirirungsi; Jullapong Achalapong; Prapap Yuthavisuthi; Prateep Kanjanavikai; Orada P Na Ayudhaya; Thitiporn Siriwachirachai; Sinart Prommas; Prapan Sabsanong; Aram Limtrakul; Supang Varadisai; Chaiwat Putiyanun; Pornnapa Suriyachai; Prateung Liampongsabuddhi; Suraphan Sangsawang; Wanmanee Matanasarawut; Sudanee Buranabanjasatean; Pichit Puernngooluerm; Chureeratana Bowonwatanuwong; Thanyawee Puthanakit; Virat Klinbuayaem; Satawat Thongsawat; Sombat Thanprasertsuk; George K Siberry; Diane H Watts; Nahida Chakhtoura; Trudy V Murphy; Noele P Nelson; Raymond T Chung; Stanislas Pol; Nantasak Chotivanich
Journal:  N Engl J Med       Date:  2018-03-08       Impact factor: 91.245

3.  Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-07-01       Impact factor: 25.391

4.  Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-07-23       Impact factor: 56.272

5.  Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based study.

Authors:  Moon S Chen; Dao M Fang; Susan L Stewart; May Ying Ly; Serge Lee; Julie H T Dang; Tram T Nguyen; Annette E Maxwell; Christopher L Bowlus; Roshan Bastani; Tung T Nguyen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-23       Impact factor: 4.254

6.  AASLD guidelines for treatment of chronic hepatitis B.

Authors:  Norah A Terrault; Natalie H Bzowej; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; M Hassan Murad
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

7.  Patterns and co-occurrence of risk factors for hepatocellular carcinoma in four Asian American communities: a cross-sectional study.

Authors:  Susan L Stewart; Julie Ht Dang; Natalie J Török; Moon S Chen
Journal:  BMJ Open       Date:  2019-06-28       Impact factor: 2.692

8.  Electronic health record alerts enhance mass screening for chronic hepatitis B.

Authors:  Eric Chak; Chin-Shang Li; Moon S Chen; Scott MacDonald; Christopher Bowlus
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

9.  An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States.

Authors:  Robert J Wong; Carol L Brosgart; Sue Welch; Tim Block; Mark Chen; Chari Cohen; W Ray Kim; Kris V Kowdley; Anna S Lok; Naoky Tsai; John Ward; Steven S Wong; Robert G Gish
Journal:  Hepatology       Date:  2021-05-26       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.